Voluntis Announces Election of Eric Elliott as Chairman of the Board of Directors

PARIS, June 15, 2015 /PRNewswire/ --

Voluntis announced today that the Board of Directors has elected Eric Elliott as its new Non-Executive Chairman of the Board effective immediately following the retirement of Yves Barbieux, who has served as Non-Executive Chairman since 2008.

     (Logo: http://photos.prnewswire.com/prnh/20140428/683170 )

     (Photo: http://photos.prnewswire.com/prnh/20150615/748944 )

"I would like to thank Yves Barbieux for his exceptional leadership of the Voluntis Board. His contributions were critical to the growth of the Company and we wish him the best for the future. As we look forward to Mr. Elliott's leadership as our new Chairman, we are fortunate to have the benefit of an outstanding life science leader who has previously led Prime Therapeutics, one of the USA's largest PBM companies. Eric Elliott's in-depth knowledge of our industry will be an invaluable asset to support our on-going efforts to accelerate our strategic growth initiatives and expand our collaborations with leading healthcare partners." said Pierre Leurent, founder and CEO, Voluntis.

"I am excited to join the Board because I believe Voluntis has a bold positioning and a unique combination of expertise to deliver on the promise of digital therapeutic solution in multiple chronic diseases. I look forward to working with the management team and contributing to the company's future" said Eric Elliott.

Eric Elliott Biography 

In his most recent role as Prime Therapeutics' President and Chief Executive Officer, Eric Elliott was responsible for all operating and strategic aspects of the full service pharmacy benefit management company. With approximately $17 billion in annualized drug spend under management, Prime Therapeutics is the fourth largest pharmacy benefit manager in the United States, servicing 23 health plans, other smaller PBMs, and employer direct customers. Critical to the success of Prime Therapeutics, Eric led the partnership with Blue Cross and Blue Shield Plans to ensure members receive the highest quality of care while managing to the appropriate pharmaceutical cost and trend. Under Elliott's leadership, Prime was recognized locally and nationally by prominent publications and organizations for its employee engagement, healthy workplace, highest quality and care of service for members, and business growth. With experience running three integrated PBMs, Eric is skilled in leading and growing businesses, to include line and segment expansions.

Eric Elliott previously served as president of Cigna's Pharmacy Management and Voluntary businesses and has held senior executive level positions at Aetna, PCS HealthSystems and Rite Aid Corporation.

Elliott received his bachelor's degree in management and finance, and a Master of Business Administration from Temple University in Philadelphia. He has served for many years on the board of directors at Prime, The Main Street America Group, the Pharmaceutical Care Management Association, and the Twin Cities American Heart Association. Elliott also serves on The Wall Street Journal CEO Council.

About Voluntis 

Pioneering therapeutic companion software, Voluntis innovates healthcare by embedding connectivity in therapeutics and medical intelligence in software. Dedicated to managing chronic conditions, Voluntis' companion software aim to enable treatment personalization, support team-care coordination, and improve real-world outcomes. Harnessing its proprietary technology, Voluntis has developed digital solution for diabetes, respiratory, oncology, anticoagulation, and hemophilia. Voluntis is headquartered in Paris, France, and has offices in Boston, USA. http://www.voluntis.com

SOURCE Voluntis